文献速递乳腺CT

前哨淋巴结活检时代腋窝淋巴结照射实践:当代可用三维技术与调强放疗技术的比较

Axillary nodal irradiation practice in the sentinel lymph node biopsy era: Comparison of the contemporary available 3D and IMRT techniques.
PubMed 文献 · Br J Radiol · 2020-04-01

研究纳入30例接受区域淋巴结照射(含腋窝)的乳腺癌患者,对每例生成传统技术、AMAROS技术与IMRT三套盲法剂量学计划。IMRT在淋巴结站覆盖与热点控制上最优,AMAROS技术热点最少且危及器官受量较低;作者认为前哨淋巴结活检有限受累且未行腋窝淋巴结清扫者可选AMAROS技术,更晚期肿瘤或原发系统治疗未反应者应考虑传统技术或IMRT。

要点

  • IMRT对I–IV站V95%覆盖最高,腋窝与锁骨上区V105%热点最少。
  • AMAROS技术腋窝与锁骨上区V105%分别为1.2 cc与0.02 cc,低于传统技术的21.3 cc与6.4 cc。
  • 同侧肺V20以IMRT最低(13.3%),传统技术16.9%、AMAROS技术16.4%。

诊断标准与关键数值

  • 靶区覆盖以V95%、D95%、淋巴结站内平均剂量与最小剂量评价,热点以V105%、V108%与最大剂量评价。
  • I、II、III、IV站平均V95%:传统技术35.8%与75%,AMAROS技术22.59%与59.9%,IMRT 45.58%与99.6%,差异有统计学意义(p < 0.001)。
  • 腋窝与锁骨上站平均V105%(cc):传统技术21.3与6.4,AMAROS技术1.2与0.02,IMRT 0.5与0.4,差异有统计学意义(p < 0.001)。
  • 同侧肺平均V20:传统技术16.9%、AMAROS技术16.4%、IMRT 13.3%;平均心脏剂量:传统技术0.3 Gy、AMAROS技术0.2 Gy、IMRT 0.2 Gy。
  • 臂丛最大剂量:传统技术50.3 Gy、AMAROS技术46.3 Gy、IMRT 47.3 Gy;腋窝-胸外侧血管交界区最大剂量:传统技术52.3 Gy、AMAROS技术47.3 Gy、IMRT 47.6 Gy;危及器官差异均有统计学意义(p < 0.001)。

局限性

  • 作者指出这些剂量学差异的临床影响尚需研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Our study aimed to compare regional node coverage and doses to the organ at risk (OAR) using conventional technique (CT) vs "AMAROS" (AT) vs intensity-modulated radiation therapy (IMRT) techniques in patients receiving regional nodal irradiation (RNI) for breast cancer (BC).

METHODS: We included 30 consecutive patients with BC who received RNI including axillary nodes. Two independent and blinded dosimetric RNI plans were generated for all patients. For target volume coverage, we analyzed the V95%, the D95%, the mean and the minimal dose within the nodal station. For hotspots within nodal target volume, we used the V105%, the V108% and the maximal doses. For OAR, lung V20, mean lung and heart doses, the maximal dose to the brachial plexus and the axillary-lateral thoracic vessel junction region were compared between the three techniques.

RESULTS: Target volume coverage and hotspots: Mean V95% in stations I, II, III and IV were 35.8% and 75% respectively with CV, 22.59 and 59.9% respectively with AT technique and 45.58 and 99.6% respectively with IMRT with statistically significant differences (p < 0.001). Mean V105% (cc) in axillary and supraclavicular stations were 21.3 and 6.4 respectively with CV, 1.2 and 0.02 respectively with AT technique and 0.5 and 0.4 respectively with IMRT with statistically significant differences (p < 0.001)..OARs: The mean ipsilateral lung V20 was 16.9%, 16.4 and 13.3% with CT, AT and IMRT respectively. The mean heart dose (Gy) was 0.3, 0.2 and 0.2 with CT, AT and IMRT respectively. The maximal dose to the plexus brachial (Gy) was 50.3, 46.3 and 47.3 with CT, AT and IMRT respectively. The maximal dose to the axillary-lateral thoracic vessel junction (Gy) was 52.3, 47.3 and 47.6 with CT, AT and IMRT respectively. The differences were statistically significant for all OAR (p < 0.001).

CONCLUSION: AT is a valuable technique for RNI including axilla in patients with limited sentinel lymph node biopsy involvement without additional axillary lymph node dissection since it decreases hotspots in the target volume and lowers the radiation exposure of the OAR. For more advanced tumors or patients who did not respond to primary systemic therapy, CT or IMRT should be considered because of their better coverage of the potentially residual nodal disease. IMRT combines several advantages of offering high conformal plans, limited hotspots and protection of main OAR. The clinical impact of these dosimetric differences need to be addressed.

ADVANCES IN KNOWLEDGE: This study is to our knowledge the first to compare conventional three-dimensional and IMRT techniques for regional nodal irradiation for each nodal station in breast cancer in a context of increasing utilization of axillary irradiation.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Belkacemi Y, Loganadane G, Ghith S, et al. Axillary nodal irradiation practice in the sentinel lymph node biopsy era: Comparison of the contemporary available 3D and IMRT techniques. Br J Radiol. 2020. PMID: 32233939. doi:10.1259/bjr.20190351

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。